Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa FeverVanessa N Raabe, Gerrit Kann, Bruce S Ribner, et al.Neuro-Oncology Advances|June 23, 2022
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updatesGerrit H Gielen, Joshua N Baugh, Dannis G van Vuurden, et al.Cancer|October 21, 2021
Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patientsRosdali Y Diaz Coronado, Martin Mynarek, Christian Koelsche, et al.Cancer Discovery|September 23, 2021
Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine GliomaDiana M Carvalho, Peter J Richardson, Nagore Olaciregui, et al.Neuro-Oncology Advances|January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine gliomaRyan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.The Journal of Pathology. Clinical Research|April 10, 2021
Prognostic value of patient-derived xenograft engraftment in pediatric sarcomasHelena Castillo-Ecija, Guillem Pascual-Pasto, Sara Perez-Jaume, et al.Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.Neuro-Oncology Advances|December 31, 2025
An innovative virtual fellowship leveraging global and regional mentorship to foster pediatric neuro-oncologists in low/middle-income countriesZeena Salman, Daniel C Moreira, Rahat Ul Ain, et al.Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.Pageof 7